As you can see, this stock has been maintaining a steady and consistent uptrend, showing strong price structure over time.
On the fundamental side, the story remains equally compelling, with a healthy upward revision to full-year guidance and notable confidence from major institutions that have been aggressively raising their price targets.
Management also increased full-year EPS guidance to a range of $7.50 to $7.74, up from the previous $7.02 to $7.36, which comes in comfortably above Wall Street’s pre-earnings consensus of around $7.31 to $7.32. Overall, both the technical trend and improving fundamentals appear aligned, supporting the ongoing bullish momentum.
On the fundamental side, the story remains equally compelling, with a healthy upward revision to full-year guidance and notable confidence from major institutions that have been aggressively raising their price targets.
Management also increased full-year EPS guidance to a range of $7.50 to $7.74, up from the previous $7.02 to $7.36, which comes in comfortably above Wall Street’s pre-earnings consensus of around $7.31 to $7.32. Overall, both the technical trend and improving fundamentals appear aligned, supporting the ongoing bullish momentum.
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。